Prognostic value of peri-operative circulating tumour DNA levels estimated by cell-free DNA methylation in patients with resectable colorectal liver metastases
Stavros Makrodimitris(Erasmus MC), Saskia M. Wilting(Amsterdam UMC Location Vrije Universiteit Amsterdam), Corine M. Beaufort(Erasmus MC Cancer Institute), Joachim Boers(Erasmus MC), Wilfred FJ van IJcken(Erasmus MC), Vanja de Weerd(Erasmus MC), Teoman Deger(Erasmus MC Cancer Institute), Maurice Jansen(Erasmus MC Cancer Institute), Eric J.T. Belt(Albert Schweitzer Ziekenhuis), Stefan Sleijfer(Erasmus MC Cancer Institute), John W.M. Martens(Erasmus MC), Dirk J. Grünhagen(Erasmus MC), Daan Hazelaar(Erasmus MC Cancer Institute), Jaco Kraan(Erasmus MC Cancer Institute), Henk M.W. Verheul(Erasmus MC Cancer Institute), Joost Gribnau(Erasmus MC), Lissa Wullaert(Erasmus MC Cancer Institute), Mark A. van de Wiel(Amsterdam University Medical Centers), Paul D. Gobardhan(Amphia Ziekenhuis), Ruben Boers(Erasmus MC), Cornelis Verhoef(Erasmus MC Cancer Institute), Maarten Vermaas(Association of British Orchestras)
Cited by 0
Related Papers
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
|New England Journal of Medicine|2012|5.5k
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|795